vs
Side-by-side financial comparison of DOMO, INC. (DOMO) and SOLENO THERAPEUTICS INC (SLNO). Click either name above to swap in a different company.
DOMO, INC. is the larger business by last-quarter revenue ($79.4M vs $66.0M, roughly 1.2× SOLENO THERAPEUTICS INC). SOLENO THERAPEUTICS INC runs the higher net margin — 39.4% vs -13.1%, a 52.5% gap on every dollar of revenue. SOLENO THERAPEUTICS INC produced more free cash flow last quarter ($43.5M vs $1.1M).
Domo, Inc. is an American cloud software company based in American Fork, Utah, United States. It specializes in artificial intelligence, business intelligence, and data visualization and is designed to provide real-time access to business data for decision makers across the company with minimal IT involvement. It is a Software-as-a-Service (SaaS) venture.
SOLENO THERAPEUTICS INC is a clinical-stage biopharmaceutical company specializing in developing novel therapies for rare endocrine, metabolic, and neurodevelopmental disorders. Its lead product candidate targets Prader-Willi syndrome, a rare genetic condition, with key patient markets across North America and the European Union.
DOMO vs SLNO — Head-to-Head
Income Statement — Q3 FY2026 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $79.4M | $66.0M |
| Net Profit | $-10.4M | $26.0M |
| Gross Margin | 74.2% | 98.3% |
| Operating Margin | -8.7% | 33.5% |
| Net Margin | -13.1% | 39.4% |
| Revenue YoY | -0.5% | — |
| Net Profit YoY | 44.6% | 134.0% |
| EPS (diluted) | $-0.25 | $0.47 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $79.4M | — | ||
| Q3 25 | $79.7M | $66.0M | ||
| Q2 25 | $80.1M | $32.7M | ||
| Q1 25 | $78.8M | — | ||
| Q4 24 | $79.8M | — | ||
| Q3 24 | $78.4M | — | ||
| Q2 24 | $80.1M | — | ||
| Q1 24 | $80.2M | — |
| Q4 25 | $-10.4M | — | ||
| Q3 25 | $-22.9M | $26.0M | ||
| Q2 25 | $-18.1M | $-4.7M | ||
| Q1 25 | $-17.7M | — | ||
| Q4 24 | $-18.8M | — | ||
| Q3 24 | $-19.5M | — | ||
| Q2 24 | $-26.0M | — | ||
| Q1 24 | $-18.7M | — |
| Q4 25 | 74.2% | — | ||
| Q3 25 | 74.8% | 98.3% | ||
| Q2 25 | 74.2% | 97.9% | ||
| Q1 25 | 74.4% | — | ||
| Q4 24 | 75.0% | — | ||
| Q3 24 | 74.3% | — | ||
| Q2 24 | 74.1% | — | ||
| Q1 24 | 76.3% | — |
| Q4 25 | -8.7% | — | ||
| Q3 25 | -9.1% | 33.5% | ||
| Q2 25 | -17.9% | -20.0% | ||
| Q1 25 | -15.6% | — | ||
| Q4 24 | -13.9% | — | ||
| Q3 24 | -18.5% | — | ||
| Q2 24 | -26.8% | — | ||
| Q1 24 | -16.6% | — |
| Q4 25 | -13.1% | — | ||
| Q3 25 | -28.8% | 39.4% | ||
| Q2 25 | -22.5% | -14.4% | ||
| Q1 25 | -22.4% | — | ||
| Q4 24 | -23.5% | — | ||
| Q3 24 | -24.9% | — | ||
| Q2 24 | -32.5% | — | ||
| Q1 24 | -23.3% | — |
| Q4 25 | $-0.25 | — | ||
| Q3 25 | $-0.56 | $0.47 | ||
| Q2 25 | $-0.45 | $-0.09 | ||
| Q1 25 | $-0.45 | — | ||
| Q4 24 | $-0.48 | — | ||
| Q3 24 | $-0.51 | — | ||
| Q2 24 | $-0.69 | — | ||
| Q1 24 | $-0.51 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $498.9M |
| Total DebtLower is stronger | $124.2M | — |
| Stockholders' EquityBook value | $-191.9M | $494.8M |
| Total Assets | $201.6M | $599.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | — | $498.9M | ||
| Q2 25 | $47.2M | $286.8M | ||
| Q1 25 | $45.3M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $61.2M | — | ||
| Q1 24 | $60.9M | — |
| Q4 25 | $124.2M | — | ||
| Q3 25 | $121.9M | — | ||
| Q2 25 | $119.7M | — | ||
| Q1 25 | $117.7M | — | ||
| Q4 24 | $115.6M | — | ||
| Q3 24 | $115.2M | — | ||
| Q2 24 | $114.1M | — | ||
| Q1 24 | $113.5M | — |
| Q4 25 | $-191.9M | — | ||
| Q3 25 | $-191.5M | $494.8M | ||
| Q2 25 | $-178.7M | $240.1M | ||
| Q1 25 | $-177.2M | — | ||
| Q4 24 | $-171.2M | — | ||
| Q3 24 | $-166.4M | — | ||
| Q2 24 | $-163.5M | — | ||
| Q1 24 | $-153.5M | — |
| Q4 25 | $201.6M | — | ||
| Q3 25 | $195.7M | $599.9M | ||
| Q2 25 | $189.7M | $332.3M | ||
| Q1 25 | $214.3M | — | ||
| Q4 24 | $190.2M | — | ||
| Q3 24 | $197.8M | — | ||
| Q2 24 | $204.4M | — | ||
| Q1 24 | $225.7M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $3.4M | $43.5M |
| Free Cash FlowOCF − Capex | $1.1M | $43.5M |
| FCF MarginFCF / Revenue | 1.4% | 65.8% |
| Capex IntensityCapex / Revenue | 2.9% | 0.0% |
| Cash ConversionOCF / Net Profit | — | 1.67× |
| TTM Free Cash FlowTrailing 4 quarters | $9.9M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.4M | — | ||
| Q3 25 | $3.4M | $43.5M | ||
| Q2 25 | $4.0M | $-12.6M | ||
| Q1 25 | $8.9M | — | ||
| Q4 24 | $-13.7M | — | ||
| Q3 24 | $-6.2M | — | ||
| Q2 24 | $1.9M | — | ||
| Q1 24 | $5.4M | — |
| Q4 25 | $1.1M | — | ||
| Q3 25 | $1.0M | $43.5M | ||
| Q2 25 | $1.0M | $-12.6M | ||
| Q1 25 | $6.7M | — | ||
| Q4 24 | $-16.2M | — | ||
| Q3 24 | $-8.4M | — | ||
| Q2 24 | $-625.0K | — | ||
| Q1 24 | $2.9M | — |
| Q4 25 | 1.4% | — | ||
| Q3 25 | 1.3% | 65.8% | ||
| Q2 25 | 1.3% | -38.6% | ||
| Q1 25 | 8.5% | — | ||
| Q4 24 | -20.3% | — | ||
| Q3 24 | -10.7% | — | ||
| Q2 24 | -0.8% | — | ||
| Q1 24 | 3.6% | — |
| Q4 25 | 2.9% | — | ||
| Q3 25 | 2.9% | 0.0% | ||
| Q2 25 | 3.7% | 0.0% | ||
| Q1 25 | 2.8% | — | ||
| Q4 24 | 3.2% | — | ||
| Q3 24 | 2.8% | — | ||
| Q2 24 | 3.2% | — | ||
| Q1 24 | 3.1% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.67× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DOMO
| Subscription | $71.9M | 91% |
| Professional Servicesand Other | $7.5M | 9% |
SLNO
Segment breakdown not available.
